Access cutting-edge uveitis treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access uveitis specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related uveitis treatment provided free
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Sponsor: Priovant Therapeutics, Inc.
Check if you qualify for this uveitis clinical trial in Phoenix, AZ
If you're searching for uveitis treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced uveitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.